This one has a reasonably settled answer, so here it is. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.
Asked to pay by a method with no recourse, by a supplier I had used twice before without being asked, which is what made me stop.
What I actually want to know is how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
I have searched first, so if this is covered somewhere point me at it and I will read it.
Dr.AddMedPHL said:Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…
Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsMounjBrad said:Asked to pay by a method with no recourse, by a supplier I had used twice before without being asked, which is what made me stop.
This matches mine closely enough to be worth saying so out loud.
Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.
Ask again with the specifics and you will get a better answer than this one.